Pli­ant shares spike on ex­plorato­ry study re­sults of lead drug in chron­ic liv­er dis­ease

Pli­ant Ther­a­peu­tics shared ear­ly-stage bio­mark­er and imag­ing re­sults, sug­gest­ing that pa­tients with a chron­ic liv­er dis­ease who re­ceived its drug had im­proved liv­er func­tion com­pared …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER